Heparin-induced thrombocytopenia and COVID-19: simplified rule of diagnosis and treatment algorithm
Abstract
Introduction. Thrombocytopenia significantly increases the risk of complications and mortality during surgical interventions, especially in general surgical, cardiac, traumatological and vascular patients. The causes of it in the postoperative period are more often blood
Pharmacokinetic assessment of Trombital and Trombital Forte: results of two randomized crossover bioequivalence study
Abstract
Aim – evaluation of the pharmacokinetics (PK), bioequivalence and safety profile of the Trombital and Trombital Forte comparing with that of Cardiomagnyl®. Material and methods. Each of these two studies was a randomized, open, single-dose, two-arm and two
Smoking status and its relationship with early vascular aging
Abstract
Background. Smoking status is associated with structural and functional vascular changes which may lead to increased arterial stiffness and, as a consequence, the formation of early vascular aging. The aim of this study was to investigate the relationship between the
Extracorporeal membrane oxygenation in emergency interventional cardiology as an alternative to conservative inoperable: a case from practice
Abstract
ECMO is currently not a routine practice in interventional cardiology. Meanwhile, the timely application of the method prevents the development of potential life-threatening complications. The aim of this report was to present our own experience in using ECMO as a
Comorbidity in patients with cardiovascular disease who underwent a new coronavirus infection
Abstract
According to Rosstat data for 2020, the total mortality in Russia against the background of the COVID‑19 pandemic increased by 19.2%. In parallel, there was also an increase in mortality from cardiovascular diseases (CVD) by 11.8%. Negative dynamics can be caused by a
Clinical cases of chronic heart failure in cancer patients
Abstract
Oncological pathology is the second cause of morbidity and mortality in the world after cardiovascular disease. Physician needs to take into account the mutual influence of these two conditions for a comprehensive patient-oriented approach to the timely diagnosis of both the
A clinical case of diuretic therapy-resistant edematous syndrome in an older patient with chronic heart failure and COVID 19
Abstract
Patients with edematous syndrome are found in the clinical practice of various doctors specialties. Diuretics are an integral part of therapy for patients with chronic heart failure, pathologies of the liver or kidneys. However, adequate and effective treatment of edematous
Growth differentiation factor 15, treatment with liraglutide, and clinical outcomes among patients with heart failure
Abstract
Aims. Associations between growth differentiation factor‑15 (GDF‑15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HFrEF) are unknown. We